Maple Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3M Buy
46,036
+9,473
+26% +$4.14M 1.09% 25
2026
Q1
$16.9M Sell
36,563
-824
-2% -$417K 1.13% 29
2025
Q4
$21.2M Sell
37,387
-206
-0.5% -$110K 1.33% 26
2025
Q3
$16.8M Sell
37,593
-762
-2% -$366K 1.1% 27
2025
Q2
$20.8M Sell
38,355
-268
-0.7% -$140K 1.43% 23
2025
Q1
$19.1M Sell
38,623
-1,020
-3% -$564K 1.48% 25
2024
Q4
$20.7M Buy
39,643
+1,181
+3% +$615K 1.52% 23
2024
Q3
$18.9M Buy
38,462
+1,838
+5% +$856K 1.44% 26
2024
Q2
$16.3M Buy
36,624
+2,584
+8% +$1.03M 1.32% 27
2024
Q1
$13.6M Buy
34,040
+4,945
+17% +$1.87M 1.24% 30
2023
Q4
$9.82M Buy
29,095
+8,018
+38% +$2.39M 0.98% 33
2023
Q3
$6.16M Buy
21,077
+4,352
+26% +$1.36M 0.7% 34
2023
Q2
$5.72M Buy
+16,725
New +$5.06M 0.62% 35

Other funds holding ISRG

Maple Capital Management's ISRG Position: Q2 2026 in Review

Maple Capital Management increased its Intuitive Surgical (ISRG) stake by 26% in Q2 2026, buying an estimated $4.14M and bringing the position to 46,036 shares worth $18.3M. The position accounts for 1.09% of the portfolio, ranked #25.

Maple Capital Management first reported a position in ISRG in Q2 2023 and has held it in 13 quarters since. The position peaked at $21.2M in Q4 2025. 2,251 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Maple Capital Management held 46,036 shares of Intuitive Surgical worth $18.3M as of Q2 2026.
  • Maple Capital Management bought 9,473 Intuitive Surgical shares in Q2 2026, an estimated $4.14M.
  • Intuitive Surgical made up 1.09% of Maple Capital Management's portfolio in Q2 2026, its #25 holding.
  • Maple Capital Management first reported a position in Intuitive Surgical in Q2 2023 and has held it in 13 quarters since.
  • Maple Capital Management's Intuitive Surgical position peaked at $21.2M in Q4 2025.
  • 2,251 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Maple Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.